Research Peptides · Cat. 005-22
prepro-ANP (104-123) (Human)
Supplied as 200 µg per unit. Purity ≥ 95%. Molecular weight 2183.56. Species: Human. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.
Specifications
| Catalog number | 005-22 |
|---|---|
| Product type | Research Peptides |
| Peptide family | Atrial Natriuretic Peptide (ANP) |
| Species | Human |
| Unit size | 200 µg |
| Molecular weight | 2183.56 Da |
| Purity | ≥ 95% |
| Validation | Exhibits correct molecular weight |
| Appearance | White powder |
| Contents | Each vial contains 200 µg of NET peptide. PTHrP produced by myeloma plasma cells regulates their survival and pro-osteoclast activity for bone disease progression. Cafforio P, Savonarola A, Stucci S, et al. J Bone Miner Res. 2014;29(1):55-66. Cardiac hormones target nuclear oncogenes c-Fos and c-Jun in carcinoma cells. Manimala NJ, Frost CD, Lane ML, Higuera M, Beg R, Vesely DL. Eur J Clin Invest. 2013;43(11):1156-62. Central role of β-catenin in anticancer effects of cardiac hormones. Skelton WP, Skelton M, Vesely DL. Anticancer Res. 2013;33(6):2409-14. Four cardiac hormones eliminate 4-fold more human glioblastoma cells than the green mamba snake peptide. Vesely BA, Eichelbaum EJ, Alli AA, Sun Y, Gower WR, Vesely DL. Cancer Lett. 2007;254(1):94-101. Vessel dilator: most potent of the atrial natriuretic peptides in decreasing the number and DNA synthesis of human squamous lung cancer cells. Vesely BA, Fitz SR, Gower WR, Vesely DL. Cancer Lett. 2006;233(2):226-31. Five cardiac hormones decrease the number of human small-cell lung cancer cells. Vesely BA, Song S, Sanchez-ramos J, et al. Eur J Clin Invest. 2005;35(6):388-98. |
| Solubility | Soluble in water |
| Intended use | In vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes |
Sequence
Ser-Ser-Asp-Arg-Ser-Ala-Leu-Leu-Lys-Ser-Lys-Leu-Arg-Ala-Leu-Leu-Thr-Ala-Pro-Arg
Storage & handling
Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.
Confirm handling and preparation requirements against current product documentation and the requirements of your laboratory protocol.
Frequently asked
What is prepro-ANP (104-123) (Human)?
What purity is listed for 005-22?
How should prepro-ANP (104-123) (Human) be stored?
What is the sequence of prepro-ANP (104-123) (Human)?
What is the intended use of 005-22?
This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.